HEALTH● LOWSep 15 · Sep 15, 2026, 8:21 AM
J&J reports phase 2b data on less-frequent lung cancer treatment
Seeking Alpha Tech · global
J&J has reported phase 2b data regarding a less-frequent treatment for lung cancer. This is a development in medical research that could impact future cancer therapies.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH20m agoProbiotic cuts risk of respiratory infections in formula-fed babiesNew ScientistHEALTH50m agoCleft lip and palate and other craniofacial surgery for kids isn’t cosmetic, it’s lifesavingThe HillHEALTH1h agoHong Kong’s Hospital Authority appeals for liver donor for boy, 13South China Morning PostHEALTH1h agoInside Bunia’s fight to protect families from DRC’s deadliest Ebola outbreakRFI [en]